BRUSSELS, Belgium - The European Commission initiated legal action against Portugal for failing to correctly implement two European Union (EU) directives dealing with genetically modified organisms (GMOs...And the European Commission (EC), which has conducted an investigation of the national laws, concluded that the obligations of the two directives are not accurately reflected

This approval process is one of the critical mechanisms which are supposed to protect the EU from unlicensed imports of GMOs - a particularly sensitive issue now that the European Commission (EC) is facing tough questioning from the European Parliament on how effectively it is exercising sufficient protection for consumers against unwitting consumption of genetically modified foods...On that occasion," she said, "the European Commission reminded the member states of their obligation to organize

Most applications for the designation of orphan medicinal products are filed by small firms specializing in biotechnology and genetic engineering, since the vast majority of rare diseases are developmental disorders of a genetic or other kind," said the European Commission (EC) in a preliminary draft, which draws heavily on U.S...The Italian Euro-MP, who is preparing a report on the subject for the EP, won applause for a fierce attack on EU delays and for his querying as to "whether there was any

and Philippe de Taxis du Pot, from the European Commission...The European Commission's biotechnology division head, Etienne Magnien, told the meeting, "An entrepreneurial spirit in biotechnology is communicable once it has proven successful anywhere in Europe

BRUSSELS, Belgium - The European Parliament has given its backing at last to the European Commission's plan to boost patent protection for biotechnology products

Other points made in the report include a proposal for increased financial and human resources to back up the regulation, and some criticisms of the European Commission for not doing enough to promote exchanges between gene banks and to improve the quality of the resource inventory

BRUSSELS, Belgium - The marketing of four more transgenic crop varieties was formally approved by the European Commission

BRUSSELS, Belgium - The European Commission (EC) has detailed progress on a number of ongoing biotechnology research projects it supports

Not only are two of the 15 EU member states refusing to follow decisions to authorize biotech products, but the EU's own civil service, the European Commission (EC), has failed to convince the member states that the revolt should be put down

BRUSSELS, Belgium - The European Commission (EC) has initiated legal action against Portugal for failing to correctly implement two European Union directives dealing with genetically modified organisms (GMOs

This approval process is one of the critical mechanisms that are supposed to protect the European Union (EU) members states from unlicensed imports of GMOs - a particularly sensitive issue now that the European Commission (EC) is facing tough questions from the European Parliament on how effectively it is protecting consumers against unwitting consumption of genetically modified foods...On that occasion, the European Commission reminded the member states of their obligation to organize inspections

The move comes after the European Commission recommended the ban on specified risk materials — brains, spinal cords and eyes from cows, sheep and goats over one year of age as well as the spleen from sheep and goats of any age ­ should either be withdrawn or adopted...In voting for the ban, the agricultural ministers asked the European Commission to come up with a new proposal that would answer external trade problems as well as be acceptable to the member states

Expected next is the issuance of a marketing authorization by the European Commission

However, late last week, the standing veterinary committee of the European Commission (EC) failed to modify the ban, effectively leaving the original law in place

BRUSSELS, Belgium - The European Commission (EC) has been asked to sort out an apparent conflict between parallel legislative drafts on biotechnology in the European Union pipeline

Biochem Pharma Inc., of Laval, Quebec, said its licensee, Glaxo Wellcome plc, of London, received approval from the European Commission to market Combivir in the 15 member states of the European Union (EU

It asks the European Commission and the member states to expand support programs designed to mobilize equity capital for biotechnology companies and to offer corresponding tax incentives...It will now be forwarded to the European Commission and its Council of Ministers

Already, he added, the European Commission's current fourth framework program on research contains an explicit provision that no support will be provided to projects which may contravene the European Convention of Human Rights, the Charter of the United Nations or the Council of Europe Convention on Human Rights and Biomedicine...And the European Commission's current proposal, for the next research framework program from 1998 to 2002, would extend the scope of this exclusion to assure that the

The Biotech and Finance Forum is a joint initiative of the European Commission and the European Association of Securities Dealers (EASD